Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer
NCT02410044 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2020-09-10
Summary
Evaluation of patient reported outcomes (PRO) / QoL regarding typical ailments in real-life patients with bone metastases treated with osteoprotective agents.
Conditions
Sponsors & Collaborators
-
iOMEDICO AG
lead INDUSTRY
Principal Investigators
-
Mark-Oliver Zahn, MD · medical practise for oncology
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-23
- Primary Completion
- 2019-08-16
- Completion
- 2020-08-16
Countries
- Germany
More Related Trials
-
PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing
NCT06460454 ·Status: COMPLETED
-
Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study
NCT06430411 ·Status: NOT_YET_RECRUITING
-
Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate Cancer to the Bone
NCT06321679 ·Status: RECRUITING
-
MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
NCT01464216 ·Status: ACTIVE_NOT_RECRUITING
-
Whole Body Magnetic Resonance Imaging Study
NCT04117594 ·Status: UNKNOWN
-
PET/MRI for Men Being Considered for Radiotherapy for Suspected Prostate Cancer Recurrence Post-Prostatectomy
NCT02131649 ·Status: COMPLETED ·Phase: NA
-
Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer
NCT07245745 ·Status: RECRUITING ·Phase: NA
-
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma
NCT00230386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prostate Cancer Screening With Abbreviated MRI Protocol
NCT05603351 ·Status: RECRUITING ·Phase: NA
-
Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate Cancer
NCT05078151 ·Status: UNKNOWN ·Phase: NA
-
All-in-One Prostate Cancer Staging with MRI
NCT06071195 ·Status: RECRUITING
-
PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)
NCT05880446 ·Status: COMPLETED ·Phase: NA
-
Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer
NCT00010244 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnostic Performance of PET/CT-PSMA in Patients With Non-prostatic PSMA-expressing Neoplasms
NCT06835244 ·Status: ENROLLING_BY_INVITATION
-
PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer
NCT06320223 ·Status: RECRUITING
-
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life
NCT06171269 ·Status: RECRUITING ·Phase: NA
-
Assessing Quality of Life of Patients With Prostate Cancer
NCT00041301 ·Status: COMPLETED
-
Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases
NCT02454543 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Fasting and Nutritional Therapy in Patients With Advanced Metastatic Prostate Cancer
NCT02710721 ·Status: COMPLETED ·Phase: NA
-
Quantitative mpMRI to Predict Metastatic Potential of Prostate Cancer
NCT05252806 ·Status: UNKNOWN
-
Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases
NCT05106699 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
NCT02312401 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer
NCT01059513 ·Status: COMPLETED
-
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
NCT03354416 ·Status: RECRUITING
-
MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients
NCT00165386 ·Status: COMPLETED ·Phase: NA